Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of peptide humanin in China. Welcome to wholesale bulk high quality peptide humanin for sale here from our factory. Good service and reasonable price are available.
Peptide Humanin is the first endogenous polypeptide identified from the mitochondrial genome. The disulfide bond formed by its 8th cysteine residue is critical for maintaining its anti-apoptotic function. Endowed with a unique three-dimensional conformation, it can target and regulate multiple cellular pathways, exhibiting neuroprotective, anti-apoptotic and anti-inflammatory activities, and has thus become a research hotspot in the fields of aging and disease studies. Studies have confirmed that it is the only short peptide capable of antagonizing both β-amyloid toxicity and the toxic effects of familial Alzheimer's disease gene mutations. It also exerts significant neuroprotective effects in animal models of Parkinson's disease and ischemic brain injury. In addition, its levels are closely associated with longevity-with higher concentrations detected in centenarians-and it plays a role in cardiovascular protection and the regulation of oxidative stress.
Our products Form
Humanin COA
Targeted Regulation of Key Aging Pathways
Aging is essentially the progressive decline of cellular functions, driven primarily by mitochondrial dysfunction, cumulative oxidative stress and impaired autophagy. The Product exerts a remarkable anti-aging effect through multi-dimensional intervention in these key processes. As a polypeptide encoded by the mitochondrial genome, it can preferentially target mitochondria and repair organellar functional damage induced by aging-a unique advantage that distinguishes it from traditional anti-aging molecules.
In terms of autophagy regulation, studies have confirmed that It is a potent autophagy inducer. It maintains the smooth flow of cellular autophagy by upregulating the expression of autophagy-related genes, thereby reducing the accumulation of misfolded proteins and damaged organelles in senescent cells. In Caenorhabditis elegans models, exogenous supplementation of Peptide Humanin significantly extends lifespan by activating the autophagic pathway, and this effect is completely abrogated in autophagy gene-knockout models, confirming the central role of autophagy in its anti-aging mechanism. Meanwhile, it improves the capacity of mitochondrial biogenesis in senescent cells, upregulates the expression of mitochondrial transcription factor A and PGC1α, increases mitochondrial DNA copy number, and restores the efficiency of cellular energy metabolism.
Oxidative stress is a major accelerator of the aging process. The Product exerts a protective effect by scavenging reactive oxygen species (ROS) and strengthening the cellular antioxidant system. In experiments on retinal pigment epithelial cells, it effectively inhibits tert-butyl hydroperoxide-induced ROS production, restores mitochondrial respiratory function, reduces the expression of cellular senescence markers SA-β-galactosidase and p16INK4a, and delays the cellular senescence process.
In addition, it suppresses "inflammaging" by downregulating the levels of pro-inflammatory cytokines IL-6 and TNF-α, mitigating the persistent damage to the organism caused by chronic inflammation.
Multi-Organ Functional Protection and Metabolic Homeostasis Maintenance
The anti-aging and health-regulating effects of It are not limited to the nervous system but extend to multiple organ systems including the cardiovascular, metabolic and ocular systems, delaying the aging process by maintaining systemic physiological homeostasis.
In cardiovascular protection, it delays the progression of age-related cardiovascular diseases such as atherosclerosis through anti-inflammatory, antioxidant and anti-apoptotic mechanisms. Studies have found that it inhibits the inflammatory response of vascular endothelial cells, reduces the expression of adhesion molecule CD62E and pro-inflammatory factor IL-1β, and alleviates endothelial damage and lipid deposition. At the same time, it protects cardiomyocytes, mitigates ischemia-reperfusion injury, maintains myocardial mitochondrial function, and reduces the risk of cardiovascular events in the elderly.
Impaired metabolic homeostasis is a key feature of aging, and it plays a critical role in the regulation of glucose and lipid metabolism. Animal experiments have shown that it improves insulin sensitivity, promotes glucose uptake and utilization, and alleviates metabolic disorders in obese and diabetic mouse models. Its mechanism is associated with the activation of the PI3K/Akt signaling pathway and the upregulation of insulin receptor expression, providing a new approach for the intervention of age-related metabolic diseases.
In addition, it exerts a protective effect on skeletal muscle function: it reduces the accumulation of abnormal proteins in myocytes by inducing autophagy, ameliorates skeletal muscle atrophy and functional decline in the elderly, and improves exercise capacity.
In the maintenance of ocular health, it protects retinal pigment epithelial cells and delays the onset and progression of age-related macular degeneration. Retinal pigment epithelial cells are highly dependent on mitochondrial function, and age-induced mitochondrial damage easily leads to cellular apoptosis. It can target and repair mitochondrial function, enhance the cellular antioxidant stress capacity, maintain the integrity of the retinal barrier, and reduce visual impairment caused by age-related macular degeneration.
Existing studies have confirmed the broad potential of Peptide Humanin in the fields of anti-aging and health regulation. Its close association with longevity also provides an important basis for translational applications-circulating levels of It in centenarians are significantly higher than in the general population, suggesting that it may be a natural longevity-regulating factor. Currently, research on its application is mainly focused on basic experiments and pretreatment models, and the core directions for the future lie in clinical translation and formulation optimization.
The main current challenges are its low bioavailability and short in vivo half-life, which limit its clinical application. In the future, its stability and tissue penetration can be improved through structural modification (e.g., analogs such as S14G-Humanin) and nanocarrier delivery technologies. At the same time, more human clinical trials are needed to verify its safety and efficacy in human anti-aging, neuroprotection and metabolic regulation.
In addition, the synergistic effects of the product with other anti-aging strategies are worthy of in-depth exploration. For example, its combined use with exercise, calorie restriction or other mitochondrially derived peptides may produce more significant health and longevity effects. With the deepening of research, it is expected to become an important target in the field of anti-aging, providing new solutions for the intervention of age-related diseases and the extension of healthy lifespan.
Origin from Neuroprotection Research (2001)
The product was independently discovered by Japanese and American research teams in 2001, a time when the human genome map had just been published and the functional exploration of the mitochondrial genome was in its infancy. When screening for bioactive molecules against Alzheimer's disease, researchers unexpectedly isolated a novel polypeptide from a human hippocampal cDNA library. Its encoding gene is not located in the nuclear genome but derived from mitochondrial DNA-a characteristic that makes it the first confirmed functionally active polypeptide encoded by the mitochondrial genome.
From Neuroprotection to the Understanding of its Pleiotropy (2001-2010)
Initial research focused on its neuroprotective function, and it was confirmed that this polypeptide can specifically antagonize β-amyloid-induced neuronal apoptosis, hence the name "Humanin". Over the following decade, three major research groups, including the team led by Pinchas Cohen at the University of Southern California, further verified that it can simultaneously inhibit the toxic effects of familial Alzheimer's disease gene mutations and exert a protective effect on dopaminergic neurons in Parkinson's disease models.
Meanwhile, studies found that it is widely present in the animal kingdom, and its evolutionary conservation suggests that it undertakes critical physiological functions.
Clarification of its Anti-Aging Value (2010-Present)
After 2010, the focus of research shifted to the field of anti-aging. A 2020 study published in the journal Aging first confirmed that it can extend the lifespan of Caenorhabditis elegans and mice, and that circulating levels in centenarians are significantly higher than in the general population. Subsequent studies have gradually revealed that it exerts its anti-aging effect by regulating mitochondrial function, autophagy and inflammatory pathways, promoting its expansion from a neuroprotective molecule to a core target in anti-aging research, and providing a new direction for the intervention of age-related diseases.
In addition, its levels are closely linked to longevity, with higher concentrations in centenarians, and it functions in cardiovascular protection and oxidative stress regulation, thus providing an important target and research tool for the intervention of neurodegenerative diseases and age-related disorders. As a mitochondrially derived peptide with multiple physiological activities, the production of Peptide Humanin must strictly comply with polypeptide synthesis standards to ensure its purity and biological activity. The core manufacturing information is presented below.
Purity and Impurity Analysis: Reversed-Phase High Performance Liquid Chromatography (RP-HPLC)
RP-HPLC is the method of choice for testing the purity of it. A C18 chromatographic column (4.6×250mm, 5μm) is adopted, with the mobile phase being acetonitrile-water (containing 0.1% trifluoroacetic acid) and a gradient elution program (the proportion of acetonitrile increased from 10% to 60% over 30 minutes) at a detection wavelength of 220nm. This method can effectively separate the target polypeptide from synthetic by-products (e.g., deletion peptides, truncated peptides). Purity is calculated by the peak area normalization method, with a required minimum purity of 98% and the peak area of a single impurity not exceeding 0.5%. Meanwhile, it enables the quantitative analysis of residual solvents and salt impurities, complying with the ICH quality standards for polypeptides.
Structure and Molecular Weight Verification: Mass Spectrometry
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) is used to verify the molecular weight, with α-cyano-4-hydroxycinnamic acid as the matrix. The sample and matrix are mixed and spotted at a ratio of 1:10, with a detection range of 1000-5000Da. The theoretical molecular weight is 2687.27, and the deviation of the measured value must be controlled within ±0.01%.
The amino acid sequence is confirmed by the Edman degradation method, where the N-terminal amino acids are hydrolyzed step-by-step for derivatization and detection to ensure the accuracy of the 24 amino acid residue sequence. The integrity of disulfide bond pairing is verified by fragment ion analysis via LC-MS/MS.
Activity and Content Analysis: Cell Activity Assay and ELISA
The SH-SY5Y neuroblastoma cell model is used for activity analysis. The biological activity is evaluated by detecting the polypeptide's ability to antagonize Aβ₁₋₄₂-induced cell apoptosis, with a cell survival rate of ≥85% as the qualified standard. Enzyme-Linked Immunosorbent Assay (ELISA) is the commonly used method for content determination. Based on the principle of antigen-antibody specific binding, a double-antibody sandwich system is established with a detection range of 0.1-10ng/mL.
This method can accurately quantify the content of the product in biological samples (serum, tissue homogenate) and synthetic products, and is suitable for basic research and clinical sample analysis.
FAQ
What diseases is it linked to?
+
-
On the other hand, it is defined as a cytoprotective peptide of 24 amino acids encoded by short open reading frames within the mitochondrial genome. Both senescence and the product have been linked to several diseases, including neurodegeneration, cardiovascular disease, and cancer.
Where does it come from?
+
-
It is secreted from cells and found in circulation (plasma), as well as bound to cellular membranes, and its actions are thought to be mediated by specific receptors.
Hot Tags: peptide humanin, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Bremelanotide Powder CAS 189691 06 3, dermorphin in humans, Epitalon Powder CAS 307297 39 8, LONG R3 IGF I CAS 143045 27 6, Melanotan ii powder, Tesamorelin CAS 218949 48 5